Related references
Note: Only part of the references are listed.RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases
Snahel Patel et al.
CELL DEATH AND DIFFERENTIATION (2020)
Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold (vol 178, 585.e1, 2019)
David W. Vredevoogd et al.
CELL (2020)
Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease
Najoua Lalaoui et al.
NATURE (2020)
A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1
Panfeng Tao et al.
NATURE (2020)
Future Therapeutic Directions for Smac-Mimetics
Emma Morrish et al.
CELLS (2020)
RIPK1 polymorphisms alter the susceptibility to cervical Cancer among the Uyghur population in China
Zulipiyamu Tuoheti et al.
BMC CANCER (2020)
Single-nucleotide polymorphism rs17548629 in RIPK1 gene may be associated with lung cancer in a young and middle-aged Han Chinese population
Shimin Yang et al.
CANCER CELL INTERNATIONAL (2020)
Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammation
Lucie Laurien et al.
NATURE COMMUNICATIONS (2020)
RIPK1 prevents TRADD-driven, but TNFR1 independent, apoptosis during development
Holly Anderton et al.
CELL DEATH AND DIFFERENTIATION (2019)
Survival of Single Positive Thymocytes Depends upon Developmental Control of RIPK1 Kinase Signaling by the IKK Complex Independent of NF-κB
Louise Webb et al.
IMMUNITY (2019)
RIPK1 inhibition attenuates experimental autoimmune arthritis via suppression of osteoclastogenesis
Jooyeon Jhun et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
RIPK1 can mediate apoptosis in addition to necroptosis during embryonic development
Xuhua Zhang et al.
CELL DEATH & DISEASE (2019)
TRADD regulates perinatal development and adulthood survival in mice lacking RIPK1 and RIPK3
John P. Dowling et al.
NATURE COMMUNICATIONS (2019)
RIPK1 and death receptor signaling drive biliary damage and early liver tumorigenesis in mice with chronic hepatobiliary injury
Santosh Krishna-Subramanian et al.
CELL DEATH AND DIFFERENTIATION (2019)
Targeting RIPK1 for the treatment of human diseases
Alexei Degterev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Serine 25 phosphorylation inhibits RIPK1 kinase-dependent cell death in models of infection and inflammation
Yves Dondelinger et al.
NATURE COMMUNICATIONS (2019)
The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD
Atsushi Uematsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
ZBP1/DAI Drives RIPK3-Mediated Cell Death Induced by IFNs in the Absence of RIPK1
Justin P. Ingram et al.
JOURNAL OF IMMUNOLOGY (2019)
Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis
Jue Hou et al.
CELL DEATH & DISEASE (2019)
Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity
Annelise G. Snyder et al.
SCIENCE IMMUNOLOGY (2019)
Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis
Kim Newton et al.
NATURE (2019)
Ubiquitination of RIPK1 suppresses programmed cell death by regulating RIPK1 kinase activation during embryogenesis
Xixi Zhang et al.
NATURE COMMUNICATIONS (2019)
K63-linked ubiquitination regulates RIPK1 kinase activity to prevent cell death during embryogenesis and inflammation
Yong Tang et al.
NATURE COMMUNICATIONS (2019)
RIPK1 and Caspase-8 Ensure Chromosome Stability Independently of Their Role in Cell Death and Inflammation
Gianmaria Liccardi et al.
MOLECULAR CELL (2019)
Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseases
Yue Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Dendritic Cell RIPK1 Maintains Immune Homeostasis by Preventing Inflammation and Autoimmunity
Joanne A. O'Donnell et al.
JOURNAL OF IMMUNOLOGY (2018)
RIP kinase 1-dependent endothelial necroptosis underlies systemic inflammatory response syndrome
Matija Zelic et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Ubiquitin-Mediated Regulation of RIPK1 Kinase Activity Independent of IKK and MK2
Alessandro Annibaldi et al.
MOLECULAR CELL (2018)
RIPK1-mediated induction of mitophagy compromises the viability of extracellular-matrix detached cells
Mark A. Hawk et al.
NATURE CELL BIOLOGY (2018)
Biallelic RIPK1 mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation
Delphine Cuchet-Lourenco et al.
SCIENCE (2018)
Mind Bomb Regulates Cell Death during TNF Signaling by Suppressing RIPK1's Cytotoxic Potential
Rebecca Feltham et al.
CELL REPORTS (2018)
TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging
Daichao Xu et al.
CELL (2018)
LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis
Nieves Peltzer et al.
NATURE (2018)
Elevated A20 promotes TNF-induced and RIPK1-dependent intestinal epithelial cell death
Ricard Garcia-Carbonell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
Wei Wang et al.
CANCER CELL (2018)
TBK1 and IKKε prevent TNF-induced cell death by RIPK1 phosphorylation
Elodie Lafont et al.
NATURE CELL BIOLOGY (2018)
Tumor immune evasion arises through loss of TNF sensitivity
Conor J. Kearney et al.
SCIENCE IMMUNOLOGY (2018)
Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis
Trieu-My Van et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Kinase Activities of RIPK1 and RIPK3 Can Direct IFN-β Synthesis Induced by Lipopolysaccharide
Danish Saleh et al.
JOURNAL OF IMMUNOLOGY (2017)
Inhibitor of Apoptosis Proteins (IAPs) Limit RIPK1-Mediated Skin Inflammation
Holly Anderton et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Quantitative Phospho-proteomic Analysis of TNFα/NFκB Signaling Reveals a Role for RIPK1 Phosphorylation in Suppressing Necrotic Cell Death
Firaz Mohideen et al.
MOLECULAR & CELLULAR PROTEOMICS (2017)
MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death
Isabel Jaco et al.
MOLECULAR CELL (2017)
p38MAPK/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection
Manoj B. Menon et al.
NATURE CELL BIOLOGY (2017)
MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death
Yves Dondelinger et al.
NATURE CELL BIOLOGY (2017)
RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function
Kay Hanggi et al.
CELL DEATH & DISEASE (2017)
Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis
Jiefei Geng et al.
NATURE COMMUNICATIONS (2017)
RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome
Yingying Zhang et al.
NATURE COMMUNICATIONS (2017)
Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma
Shawn T. Beug et al.
NATURE COMMUNICATIONS (2017)
MAVS activates TBK1 and IKKε through TRAFs in NEMO dependent and independent manner
Run Fang et al.
PLOS PATHOGENS (2017)
EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation
Jaclyn S. Pearson et al.
NATURE MICROBIOLOGY (2017)
Interferon-gamma regulates inflammatory cell death by targeting necroptosis in experimental autoimmune arthritis
Seung Hoon Lee et al.
SCIENTIFIC REPORTS (2017)
Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers
Kathleen Weisel et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2017)
PD-L1 and IAPs co-operate to protect tumors from cytotoxic lymphocyte-derived TNF
Conor J. Kearney et al.
CELL DEATH AND DIFFERENTIATION (2017)
A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development
Yannick Boege et al.
CANCER CELL (2017)
Combination of IAP antagonist and IFNγ activates novel caspase-10-and RIPK1-dependent cell death pathways
Maria C. Tanzer et al.
CELL DEATH AND DIFFERENTIATION (2017)
RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver Cancer
Anne T. Schneider et al.
CANCER CELL (2017)
Lys63/Met1-hybrid ubiquitin chains are commonly formed during the activation of innate immune signalling
Christoph H. Emmerich et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked
Sabine Hannes et al.
CANCER LETTERS (2016)
Innate immune signaling through differential RIPK1 expression promote tumor progression in head and neck squamous cell carcinoma
Kevin D. McCormick et al.
CARCINOGENESIS (2016)
RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury
K. Newton et al.
CELL DEATH AND DIFFERENTIATION (2016)
IκB Kinaseα/β Control Biliary Homeostasis and Hepatocarcinogenesis in Mice by Phosphorylating the Cell-Death Mediator Receptor-Interacting Protein Kinase 1
Christiane Koppe et al.
HEPATOLOGY (2016)
NEMO Prevents RIP Kinase 1-Mediated Epithelial Cell Death and Chronic Intestinal Inflammation by NF-κB-Dependent and -Independent Functions
Katerina Vlantis et al.
IMMUNITY (2016)
RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4
Malek Najjar et al.
IMMUNITY (2016)
TNF activation of NF-κB is essential for development of single-positive thymocytes
Louise V. Webb et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
LUBAC deficiency perturbs TLR3 signaling to cause immunodeficiency and autoinflammation
Julia Zinngrebe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression
Lena Seifert et al.
NATURE (2016)
RIPK1 inhibits ZBP1-driven necroptosis during development
Kim Newton et al.
NATURE (2016)
RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation
Juan Lin et al.
NATURE (2016)
Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis
Boris Strilic et al.
NATURE (2016)
IAP antagonists induce anti-tumor immunity in multiple myeloma
Marta Chesi et al.
NATURE MEDICINE (2016)
The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia
Gabriela Brumatti et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
RIPK1 protects from TNF-α-mediated liver damage during hepatitis
Aveline Filliol et al.
CELL DEATH & DISEASE (2016)
Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity
Tania Love Aaes et al.
CELL REPORTS (2016)
NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis
Vangelis Kondylis et al.
CANCER CELL (2015)
Toll-like receptors: Activation, signalling and transcriptional modulation
Dominic De Nardo
CYTOKINE (2015)
Upregulated RIP3 Expression Potentiates MLKL Phosphorylation-Mediated Programmed Necrosis in Toxic Epidermal Necrolysis
Sue Kyung Kim et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
NF-κB-Independent Role of IKKα/IKKβ in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling
Yves Dondelinger et al.
MOLECULAR CELL (2015)
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells
Nader Yatim et al.
SCIENCE (2015)
RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL
Kate E. Lawlor et al.
NATURE COMMUNICATIONS (2015)
Genetic polymorphisms associated with increased risk of developing chronic myelogenous leukemia
Heriberto Bruzzoni-Giovanelli et al.
ONCOTARGET (2015)
LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes
Peter Draber et al.
CELL REPORTS (2015)
A novel function of RIP1 in postnatal development and immune homeostasis by protecting against RIP3-dependent necroptosis and FADD-mediated apoptosis
John P. Dowling et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2015)
Red Blood Cells Induce Necroptosis of Lung Endothelial Cells and Increase Susceptibility to Lung Inflammation
Danielle Y. Qing et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1-and RIPK3-dependent manner
W. Wei-Lynn Wong et al.
BLOOD (2014)
RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis
James A. Rickard et al.
CELL (2014)
RIPK1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPK3
Christopher P. Dillon et al.
CELL (2014)
RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis
S. Orozco et al.
CELL DEATH AND DIFFERENTIATION (2014)
RIPK1 can function as an inhibitor rather than an initiator of RIPK3-dependent necroptosis
Conor J. Kearney et al.
FEBS JOURNAL (2014)
Cutting Edge: RIPK1 Kinase Inactive Mice Are Viable and Protected from TNF-Induced Necroptosis In Vivo
Apostolos Polykratis et al.
JOURNAL OF IMMUNOLOGY (2014)
Cutting Edge: RIP1 Kinase Activity Is Dispensable for Normal Development but Is a Key Regulator of Inflammation in SHARPIN-Deficient Mice
Scott B. Berger et al.
JOURNAL OF IMMUNOLOGY (2014)
RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis
Nozomi Takahashi et al.
NATURE (2014)
RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis
Marius Dannappel et al.
NATURE (2014)
RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition
William J. Kaiser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-mediated necroptosis
Justine E. Roderick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis
Kim Newton et al.
SCIENCE (2014)
Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma
K. E. McCabe et al.
CELL DEATH & DISEASE (2014)
Receptor-interacting protein kinase 3 deficiency inhibits immune cell infiltration and attenuates organ injury in sepsis
Archna Sharma et al.
CRITICAL CARE (2014)
RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition
Y. Dondelinger et al.
CELL DEATH AND DIFFERENTIATION (2013)
Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis
Jianfeng Wu et al.
CELL RESEARCH (2013)
Masters, marionettes and modulators: intersection of pathogen virulence factors and mammalian death receptor signaling
John Silke et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Loss of Caspase-8 in Hepatocytes Accelerates the Onset of Liver Regeneration in Mice Through Premature Nuclear Factor kappa B Activation
Julia Freimuth et al.
HEPATOLOGY (2013)
The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism
James M. Murphy et al.
IMMUNITY (2013)
Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL
William J. Kaiser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
cFLIP Regulates Skin Homeostasis and Protects against TNF-Induced Keratinocyte Apoptosis
Diana Panayotova-Dimitrova et al.
CELL REPORTS (2013)
Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Liming Sun et al.
CELL (2012)
dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8
Y. Estornes et al.
CELL DEATH AND DIFFERENTIATION (2012)
IAPs limit activation of RIP kinases by TNF receptor 1 during development
Maryline Moulin et al.
EMBO JOURNAL (2012)
Genome-wide expression profiling implicates a MAST3-regulated gene set in colonic mucosal inflammation of ulcerative colitis patients
Catherine Labbe et al.
INFLAMMATORY BOWEL DISEASES (2012)
Survival Function of the FADD-CASPASE-8-cFLIPL Complex
Christopher P. Dillon et al.
CELL REPORTS (2012)
Pathogen-Mediated Proteolysis of the Cell Death Regulator RIPK1 and the Host Defense Modulator RIPK2 in Human Aortic Endothelial Cells
Andres G. Madrigal et al.
PLOS PATHOGENS (2012)
Diagnosis and Treatment in Anhidrotic Ectodermal Dysplasia with Immunodeficiency
Tomoki Kawai et al.
ALLERGOLOGY INTERNATIONAL (2012)
Novel cross-talk within the IKK family controls innate immunity
Kristopher Clark et al.
BIOCHEMICAL JOURNAL (2011)
cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production
N. Vanlangenakker et al.
CELL DEATH AND DIFFERENTIATION (2011)
RIP Kinase-Dependent Necrosis Drives Lethal Systemic Inflammatory Response Syndrome
Linde Duprez et al.
IMMUNITY (2011)
RIG-I RNA Helicase Activation of IRF3 Transcription Factor Is Negatively Regulated by Caspase-8-Mediated Cleavage of the RIP1 Protein
Akhil Rajput et al.
IMMUNITY (2011)
RIPK1 and CASP7 polymorphism as prognostic markers for survival in patients with colorectal cancer after complete resection
Yee Soo Chae et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms
Maria Feoktistova et al.
MOLECULAR CELL (2011)
The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPs
Tencho Tenev et al.
MOLECULAR CELL (2011)
SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex
Fuminori Tokunaga et al.
NATURE (2011)
Catalytic activity of the caspase-8-FLIPL complex inhibits RIPK3-dependent necrosis
Andrew Oberst et al.
NATURE (2011)
Linear ubiquitination prevents inflammation and regulates immune signalling
Bjoern Gerlach et al.
NATURE (2011)
TAK1 Suppresses a NEMO-Dependent but NF-κB-Independent Pathway to Liver Cancer
Kira Bettermann et al.
CANCER CELL (2010)
RIPK1 is not essential for TNFR1-induced activation of NF-κB
W. W-L Wong et al.
CELL DEATH AND DIFFERENTIATION (2010)
c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling
Jasmin N. Dynek et al.
EMBO JOURNAL (2010)
Crystal Structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 Complexes: Affinity, Specificity, and Regulation
Chao Zheng et al.
MOLECULAR CELL (2010)
The Receptor Interacting Protein 1 Inhibits p53 Induction through NF-κB Activation and Confers a Worse Prognosis in Glioblastoma
Seongmi Park et al.
CANCER RESEARCH (2009)
Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation
YoungSik Cho et al.
CELL (2009)
DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-κB
Manuele Rebsamen et al.
EMBO REPORTS (2009)
TRAF2 Must Bind to Cellular Inhibitors of Apoptosis for Tumor Necrosis Factor (TNF) to Efficiently Activate NF-κB and to Prevent TNF-induced Apoptosis
James E. Vince et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Recruitment of the Linear Ubiquitin Chain Assembly Complex Stabilizes the TNF-R1 Signaling Complex and Is Required for TNF-Mediated Gene Induction
Tobias L. Haas et al.
MOLECULAR CELL (2009)
Involvement of linear polyubiquitylation of NEMO in NF-κB activation
Fuminori Tokunaga et al.
NATURE CELL BIOLOGY (2009)
TNF-α induces two distinct caspase-8 activation pathways
Lai Wang et al.
CELL (2008)
TRADD protein is an essential component of the RIG-like helicase antiviral pathway
Marie-Cecile Michallet et al.
IMMUNITY (2008)
Hypomorphic nuclear factor-κB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity
Eric P. Hanson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor α (TNFα)-induced NF-κB activation
Eugene Varfolomeev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Receptor-Interacting Protein Homotypic Interaction Motif-Dependent Control of NF-κB Activation via the DNA-Dependent Activator of IFN Regulatory Factors
William J. Kaiser et al.
JOURNAL OF IMMUNOLOGY (2008)
cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination
Mathieu J. M. Bertrand et al.
MOLECULAR CELL (2008)
Identification of RIP1 kinase as a specific cellular target of necrostatins
Alexei Degterev et al.
NATURE CHEMICAL BIOLOGY (2008)
The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptors
Yelena L. Pobezinskaya et al.
NATURE IMMUNOLOGY (2008)
Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses
Maria A. Ermolaeva et al.
NATURE IMMUNOLOGY (2008)
Beyond tumor necrosis factor receptor:: TRADD signaling in toll-like receptors
Nien-Jung Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain
Shanshan Feng et al.
CELLULAR SIGNALLING (2007)
Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis
R. E. Seymour et al.
GENES AND IMMUNITY (2007)
Role of caspase-8 in hepatocyte response to infection and injury in mice
Tehila Ben Moshe et al.
HEPATOLOGY (2007)
Epithelial NEMO links innate immunity to chronic intestinal inflammation
Arianna Nenci et al.
NATURE (2007)
Deletion of NEMO/IKKγ in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma
Tom Luedde et al.
CANCER CELL (2007)
Ubiquitination of RIP is required for tumor necrosis factor α-induced NF-κB activation
HX Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO
CK Ea et al.
MOLECULAR CELL (2006)
Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases
T Samuel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
MORT1/FADD is involved in liver regeneration
Marcus Schuchmann et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Rip1 mediates the Trif-dependent Toll-like receptor 3- and 4-induced NF-κB activation but does not contribute to interferon regulatory factor 3 activation
N Cusson-Hermance et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
T Kawai et al.
NATURE IMMUNOLOGY (2005)
Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif
WJ Kaiser et al.
JOURNAL OF IMMUNOLOGY (2005)
Activation of caspases-8 and-10 by FLIPL
KM Boatright et al.
BIOCHEMICAL JOURNAL (2004)
TAB2 and TAB3 activate the NF-κB pathway through binding to polyubiquitin chains
A Kanayama et al.
MOLECULAR CELL (2004)
A FADD-dependent innate immune mechanism in mammalian cells
S Balachandran et al.
NATURE (2004)
RIP1 is an essential mediator of Toll-like receptor 3-induced NF-κB activation
E Meylan et al.
NATURE IMMUNOLOGY (2004)
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
O Micheau et al.
CELL (2003)
The long form of FLIP is an activator of caspase-8 at the fas death-inducing signaling complex
O Micheau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO)
J Zonana et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Share Paper
